BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 30959886)

  • 1. Analysis of Association between Vitamin D Deficiency and Insulin Resistance.
    Szymczak-Pajor I; Śliwińska A
    Nutrients; 2019 Apr; 11(4):. PubMed ID: 30959886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Molecular Mechanisms by Which Vitamin D Prevents Insulin Resistance and Associated Disorders.
    Szymczak-Pajor I; Drzewoski J; Śliwińska A
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32932777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D deficiency and diabetes.
    Berridge MJ
    Biochem J; 2017 Mar; 474(8):1321-1332. PubMed ID: 28341729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D, sub-inflammation and insulin resistance. A window on a potential role for the interaction between bone and glucose metabolism.
    Garbossa SG; Folli F
    Rev Endocr Metab Disord; 2017 Jun; 18(2):243-258. PubMed ID: 28409320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms Involved in the Relationship between Vitamin D and Insulin Resistance: Impact on Clinical Practice.
    Contreras-Bolívar V; García-Fontana B; García-Fontana C; Muñoz-Torres M
    Nutrients; 2021 Oct; 13(10):. PubMed ID: 34684492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D deficiency: a new risk factor for type 2 diabetes?
    Mezza T; Muscogiuri G; Sorice GP; Prioletta A; Salomone E; Pontecorvi A; Giaccari A
    Ann Nutr Metab; 2012; 61(4):337-48. PubMed ID: 23208163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Vitamin D Deficiency Related to Increased Cancer Risk in Patients with Type 2 Diabetes Mellitus?
    Gabryanczyk A; Klimczak S; Szymczak-Pajor I; Śliwińska A
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D and new insights into pathophysiology of type 2 diabetes.
    Vondra K; Hampl R
    Horm Mol Biol Clin Investig; 2021 Mar; 42(2):203-208. PubMed ID: 33655734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D Deficiency, Obesity and Diabetes.
    Li YX; Zhou L
    Cell Mol Biol (Noisy-le-grand); 2015 Jun; 61(3):35-8. PubMed ID: 26068917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients.
    Borissova AM; Tankova T; Kirilov G; Dakovska L; Kovacheva R
    Int J Clin Pract; 2003 May; 57(4):258-61. PubMed ID: 12800453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 12 weeks high dose vitamin D3 treatment on insulin sensitivity, beta cell function, and metabolic markers in patients with type 2 diabetes and vitamin D insufficiency - a double-blind, randomized, placebo-controlled trial.
    Kampmann U; Mosekilde L; Juhl C; Moller N; Christensen B; Rejnmark L; Wamberg L; Orskov L
    Metabolism; 2014 Sep; 63(9):1115-24. PubMed ID: 25044176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D and cardiometabolic risk factors and diseases.
    Mousa A; Naderpoor N; Teede HJ; De Courten MP; Scragg R; De Courten B
    Minerva Endocrinol; 2015 Sep; 40(3):213-30. PubMed ID: 25714787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D and type 2 diabetes.
    Lips P; Eekhoff M; van Schoor N; Oosterwerff M; de Jongh R; Krul-Poel Y; Simsek S
    J Steroid Biochem Mol Biol; 2017 Oct; 173():280-285. PubMed ID: 27932304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of vitamin D in insulin resistance.
    Sung CC; Liao MT; Lu KC; Wu CC
    J Biomed Biotechnol; 2012; 2012():634195. PubMed ID: 22988423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 25-hydroxyvitamin D is associated with adiposity and cardiometabolic risk factors in a predominantly vitamin D-deficient and overweight/obese but otherwise healthy cohort.
    Mousa A; Naderpoor N; de Courten MPJ; Scragg R; de Courten B
    J Steroid Biochem Mol Biol; 2017 Oct; 173():258-264. PubMed ID: 28007531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic Latent Magnesium Deficiency in Obesity Decreases Positive Effects of Vitamin D on Cardiometabolic Risk Indicators.
    Stokic E; Romani A; Ilincic B; Kupusinac A; Stosic Z; Isenovic ER
    Curr Vasc Pharmacol; 2018; 16(6):610-617. PubMed ID: 28828979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of vitamin D supplementation on insulin resistance and glycaemic control in prediabetes: a systematic review and meta-analysis.
    Poolsup N; Suksomboon N; Plordplong N
    Diabet Med; 2016 Mar; 33(3):290-9. PubMed ID: 26308752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of vitamin D in the pathogenesis of type 2 diabetes mellitus.
    Palomer X; González-Clemente JM; Blanco-Vaca F; Mauricio D
    Diabetes Obes Metab; 2008 Mar; 10(3):185-97. PubMed ID: 18269634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D Deficiency and Oxidative Stress in Type 2 Diabetic Population of India.
    Dhas Y; Mishra N; Banerjee J
    Cardiovasc Hematol Agents Med Chem; 2017; 14(2):82-89. PubMed ID: 27114101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D Status and Association of
    Ahmed JH; Makonnen E; Fotoohi A; Yimer G; Seifu D; Assefa M; Tigeneh W; Aseffa A; Howe R; Aklillu E
    Nutrients; 2019 Jan; 11(2):. PubMed ID: 30699973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.